gowebcasting uses cookies in order to improve your online experience. By continuing to use gowebcasting.com, you accept our privacy policy

ProMetic reports its 2014 fourth quarter and year-end highlights and financial results

Wednesday, April 1st, 2015 at 11:00am ET

Speakers: 

Pierre Laurin, B.Sc.Pharm., M.Sc.
President & Chief Executive Officer
ProMetic Life Sciences Inc.

Mr. Pierre Laurin has over 25 years of experience in the pharmaceutical and biotechnology industry. Involved in the development of ProMetic's platform technology since 1989, Mr. Laurin founded ProMetic Life Sciences Inc. in 1994. As Chairman and CEO of the Company since its inception, he took the Company public on the Toronto Stock Exchange and has since raised over $95 million through equity financings and multinational funding. Mr. Laurin’s corporate development achievements include the successful close of some 20 licensing agreements and joint venture agreements with multinationals including the American Red Cross, Merck, and Arriva Pharmaceuticals.

Bruce Pritchard, BA, CA, MloD
Chief Operating Officer and Chief Financial Officer
ProMetic Life Sciences Inc.

Mr. Bruce Pritchard is Chief Operating Officer of the ProMetic Group, having been promoted to that position in August 2014. He originally joined ProMetic as CFO of the U.K. subsidiary, ProMetic BioSciences Ltd (PBL).in 2006 and was promoted as CFO of the group in 2008. He is a Chartered Accountant with many years of experience in corporate accountancy including senior finance positions with biotech and pharmaceutical companies He has a proven track record of building high-growth businesses, with both public capital market and private equity experience, augmented by a background in M&A and operations.

Mr. Pritchard is currently a member of both the Governing Council and Qualifications Board of The Institute of Chartered Accountants of Scotland and is a member of the Board of Examiners of The Institute of Directors. He is a Non-Executive Director and Chair of the Audit Committee of Imanova Limited and a Non-Executive Director of Being Digital Limited. A Heriot-Watt University graduate, Mr. Pritchard gained a BA in Accountancy and Computer Science in 1993, he qualified as a Member of the Institute of Chartered Accountants of Scotland in 1996.

The following information is required to view this webcast.
Please complete all of the information to continue.

Email *
First Name *
Last Name *
Company *

About ProMetic

ProMetic is a global biopharmaceutical company offering technologies for large-scale drug purification, drug development, proteomics (the study of proteins), and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission of bringing to market effective, innovative, lower cost products for the treatment of hematological and nephrological disorders and cancer. Headquartered in Montréal (Canada), ProMetic has R&D facilities in the UK, the USA and Canada, manufacturing facilities in the UK and business development activities in the USA, Europe, Asia and in the Middle-East. ProMetic focuses its activities in the Protein Technologies and Therapeutics markets.

The Bottom Line

CO2 emissions saved by using gowebcasting viewing this webcast:

Share this page on: